Aug 26, 2022, 10:05 AM by

Aug 26, 2022, 10:04 AM by

Aug 26, 2022, 10:02 AM by

Aug 26, 2022, 10:01 AM by

Aug 25, 2022, 10:16 AM by

Aug 25, 2022, 10:15 AM by

Aug 25, 2022, 10:15 AM by

Aug 25, 2022, 10:15 AM by

Aug 25, 2022, 10:14 AM by

A leader in continuous remote patient monitoring and data analytics, physIQ today announced a strategic collaboration with InCarda Therapeutics, Inc., a privately-held, clinical-stage biopharmaceutical company developing first-of-their-kind inhaled therapies for cardiovascular diseases. Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, recommended physIQ’s innovative monitoring solution to help advance InCarda’s clinical study of InRhythm™ (orally inhaled flecainide) in patients with atrial fibrillation (AF) – one of the most common heart arrhythmias that affects one in four adults over the age of 40.1

Aug 25, 2022, 10:13 AM by

Aug 25, 2022, 10:07 AM by

Aug 25, 2022, 01:00 AM by User Not Found

Bio-IT World | Researchers from the Wake Forest Institute for Regenerative Medicine and Wake Forest Organoid Research Center developed an immunoreactive tumor organoid to study microbial metabolites and their effect on immune function.

Aug 24, 2022, 09:45 AM by

GenScript ProBio announced that it has expanded its partnership with Athenex which is a leading biopharmaceutical business that is committed to the development, discovery and commercialization of innovative therapies to treat cancer and related disorders as well as the creation of cutting-edge treatments for gene and cell therapy with the benefit of a preferred collaboration.

Aug 24, 2022, 09:44 AM by

Aug 24, 2022, 08:00 AM by User Not Found

Bio-IT World | Though Parkinson’s is the second most common neurodegenerative disease, scientists know little about its etiology. Hoping to discover more, a research team at Simon Fraser University in Burnaby, British Columbia, developed a new fluorescence-based blood testing method to examine PD development and progression in neurons.

Aug 24, 2022, 01:00 AM by User Not Found

Bio-IT World | Researchers at the Massachusetts Institute of Technology have been working on “self-boosting” vaccines for a decade now. Thanks to the COVID-19 pandemic, curiosity about the underlying platform has piqued in First World nations where vaccination boosters now have personal everyday relevance.

Aug 23, 2022, 13:04 PM by

Curebase, a company committed to democratizing access to clinical studies, has named veteran clinical research executive Sean Lynch as vice president of clinical operations.

Aug 23, 2022, 01:00 AM by User Not Found

Bio-IT World | Victoria Gamerman’s love of analytics and math came from her grandmother—the first mathematician she knew. Now, as the Global Head of Data Governance and Insights at Boehringer Ingelheim, she’s using that love for data to explore real-world data for drug discovery.

Aug 19, 2022, 09:54 AM by

Aug 19, 2022, 09:52 AM by